source
- STAT+: NIAID appoints new acting director after weekslong questions over leadershipThe NIH has appointed researcher John Powers III to lead its infectious disease institute on an acting basis, after weeks of being in leadership limbo.STAT · 2mo ago↗ source
- Lilly offers up to $1B for Alzheimer's drug; Bial cuts failed Parkinson's drugPlus news about Parabilis Medicines, RA Capital, Tango Therapeutics, Ideaya Biosciences, Bavarian Nordic and Cartesian Therapeutics 💸 Lilly’s $1B Alzheimer’s deal: The Indianapolis drugmaker will…Endpoints · 2mo ago↗ source
- Trodelvy misses in lung cancer, but Gilead and Merck have an HIV successGilead Sciences and Merck have reported a hit and a miss for their Phase 3 HIV and lung cancer programs, respectively, but investors were largely braced for impact, according to Wall Street. The pa…